# Nicotinamide Mononucleotide (NMN) and Its Neuroprotective Role in Retinal Degeneration

Canonical source: https://retacompare.com/research/nicotinamide-mononucleotide-nmn-and-its-neuroprotective-role-in-retinal-degeneration

Sinclair Lab Research · 2020-12-29


    Nicotinamide mononucleotide (NMN) demonstrates significant neuroprotective effects in a model of retinal degeneration. This study, led by Prof. David Sinclair, focuses on the potential of NMN as a therapeutic agent against photoreceptor degeneration, a condition currently lacking effective pharmacotherapy. NMN, a precursor to nicotinamide adenine dinucleotide (NAD+), is investigated for its ability to improve cellular health and longevity through its influence on metabolic pathways.

 What this study examined

The research examined the effects of NMN in a retinal detachment (RD) model, which induces photoreceptor degeneration. The study involved administering NMN after RD to assess its impact on photoreceptor cell survival and associated inflammatory responses. Key outcomes included the reduction of TUNEL+ photoreceptors, normalization of protein carbonyl content, and preservation of outer nuclear layer thickness, indicating a protective effect against degeneration.

 Why this matters for longevity research

This study is significant in the context of longevity research as it highlights the role of NAD+ and its precursors, like NMN, in cellular repair and protection mechanisms. The findings suggest that enhancing NAD+ levels may not only support retinal health but also contribute to broader healthspan improvements. Given the aging population and the prevalence of age-related degenerative diseases, identifying effective neuroprotectants is crucial for extending both healthspan and lifespan.

 Key findings

NMN administration significantly reduced the number of TUNEL+ photoreceptors after retinal detachment.

There was a notable decrease in CD11b+ macrophages, indicating reduced inflammation.

Glial activation, as measured by GFAP labeling, was also significantly reduced with NMN treatment.

Protein carbonyl content (PCC) was normalized following NMN administration.

The outer nuclear layer (ONL) thickness was preserved in treated subjects.

NMN administration led to increased NAD+ levels and SIRT1 protein expression.

Delayed NMN administration still provided protective effects against oxidative stress.

 The science behind it

The neuroprotective effects of NMN are primarily attributed to its role in increasing NAD+ levels, which are essential for various cellular processes, including energy metabolism and DNA repair. NAD+ is a critical cofactor for sirtuins, a family of proteins that regulate cellular health and longevity. Specifically, SIRT1, activated by NAD+, plays a vital role in mitigating oxidative stress and inflammation, both of which are implicated in neurodegenerative diseases. The study's findings suggest that NMN's mechanism of action involves SIRT1 and heme oxygenase-1 (HO-1) signaling pathways, which are crucial for cellular protection under stress conditions.

 How it fits into the longevity field

This research aligns with the broader literature on the NAD+/sirtuin axis and its implications for aging and longevity. Previous studies have indicated that enhancing NAD+ levels can improve mitochondrial function and promote cellular resilience. Other interventions, such as caloric restriction and exercise, have also been shown to elevate NAD+ levels, suggesting a multifaceted approach to healthspan extension. NMN, as a readily available supplement, represents a promising avenue for further exploration in the context of age-related diseases.

 Practical takeaways

Researchers and informed consumers should consider the implications of NMN supplementation as a potential neuroprotective strategy. While the findings are promising, further studies are needed to fully understand the long-term effects and optimal dosing of NMN. The research underscores the importance of targeting NAD+ metabolism in efforts to extend healthspan and mitigate age-related decline. For those interested in the broader implications of NMN and related interventions, additional resources can be found in the longevity research library.

 FAQ

 What is NMN and how does it work?

Nicotinamide mononucleotide (NMN) is a precursor to NAD+, which plays a crucial role in cellular metabolism and repair. It enhances NAD+ levels, supporting sirtuin activity and cellular health.

 Can NMN help with age-related diseases?

Research suggests that NMN may provide neuroprotective effects and improve healthspan by enhancing cellular resilience and reducing inflammation, particularly in age-related conditions.

 Is NMN safe for consumption?

While NMN is considered safe in preliminary studies, further research is necessary to establish long-term safety and efficacy for various populations.

 Source: PubMed · Aging (Albany NY) · published 2020-12-29.

## Sources

- PubMed · Aging (Albany NY): https://pubmed.ncbi.nlm.nih.gov/33373320/